Why low T is rising in young men

Population data shows men's testosterone has dropped roughly 20% over the past 30 years, with younger men affected disproportionately. The drivers are largely lifestyle:

Most young men with low T have a fixable cause, not a primary endocrine disorder.

Reversible causes to address first

Before considering TRT in a man under 30, comprehensive workup should rule in or out:

The workup

Comprehensive labs for a young man with suspected low T:

First-line interventions

For young men with low T and reversible causes, the first-line approach is usually:

  1. Address sleep, 7-9 hours, treat sleep apnea if present
  2. Lose visceral fat, often via GLP-1 if substantial weight to lose
  3. Optimize nutrition, adequate calories, protein, micronutrients
  4. Resistance training 3-4 days/week
  5. Reduce alcohol
  6. Address stress, therapy, lifestyle changes, cortisol-reducing habits
  7. Vitamin D, magnesium, zinc if deficient
  8. Re-test labs at 3-6 months

Many young men recover natural T to optimal range with these alone, without needing TRT.

Why enclomiphene often beats TRT in young men

Enclomiphene blocks estrogen feedback at the hypothalamus, increasing LH/FSH and stimulating natural T production. For young men with secondary hypogonadism, this is often a better starting point than TRT because:

Limitations: only works if testes are functional; effect size smaller than TRT; some men experience visual side effects.

When TRT is appropriate in young men

Fertility considerations

Standard TRT suppresses fertility. For young men who may want children, options:

The clinical pearl: Young men with low T usually have a fixable cause. Default-to-TRT in this population is often the wrong sequence. Address the cause, try enclomiphene, then consider TRT only if those paths don't deliver.

Bottom line

TRT in men under 30 isn't wrong, but it's overused as a first-line intervention. Most young men with low T have reversible drivers that, when addressed, restore natural levels. Enclomiphene is often the better starting point for those with secondary hypogonadism. The decision to start lifelong TRT in your 20s deserves careful evaluation, not a quick prescription.

−20%
population testosterone decline over 30 years
Reversible
cause in most young men with low T
Enclomiphene
often beats TRT for young men with secondary hypogonadism